Michalis Chrysochoidis has rich and diverse experience in security policy, energy, infrastructure, markets and trade. He was also elected and served as a Member of Parliament in the Greek Parliament. He was: Minister of Citizen Protection, Infrastructure, Transport and Networks, Development of Competitiveness and Shipping and Deputy Minister of Development and Trade.

He is the longest-serving Minister, responsible for internal security issues, with terms marked by important programs for the modernization of public security, the fight against crime, the reform of the anti-terrorist policy, the modern organization of the services of the Hellenic Armed Forces and the protection of the borders. The results of this policy were combined with corresponding European and international collaborations and included the implementation of education and training programs, information exchange and technological reinforcement of the EL.AS.

The cornerstone of these policies was the dismantling of terrorism, with the referral to trial and final conviction of the members of the terrorist organization 17N. The dismantling of this organization has become an example of the effectiveness of modern counter-terrorist operations. The organization was dismantled in a bloodless manner that reaffirmed the rule of law and demonstrated the effectiveness of modern counter-terrorism approaches.

During his days, the Economic Police Directorate, the Electronic Crime Prosecution Directorate, the Bicycle Police teams (DI.AS), the Internal Affairs Service, etc. were also established and operated.

During his last term there, for the first time in the post-colonial period, the Law provided for in the Constitution on the regulation of the right of assembly was passed. Finally, the electronic border surveillance system and the fence on the country’s eastern border with Turkey were built and are operating.

In the May 2023 Elections, he was elected with the New Democracy as the first Member of Parliament in Western Athens.

In the Government of June 2023, he was assigned by the Prime Minister the portfolio of the Ministry of Health.

Dr João Breda is Special Adviser of WHO/Europe Regional Director’s for the establishment of Sub-Regional Offices and is based in Greece.

Until recently he Headed the WHO European Office for the Prevention and Control of NCDs, which is an integral part of the WHO Regional Office for Europe. Led by Dr Breda, the NCD Office provided support to 53 Member States in the WHO European Region based on population-level, targeted approaches to ensure a reduction in NCD risk, an overall decline in premature mortality. In 2019, the team he was leading was given an Award of Excellence announced by Dr Tedros Adhanom Ghebreyesus, WHO Director-General, which acknowledges the exceptional contribution to the Organization, tangible gains and achievements.

For eleven years Dr João Breda was Programme Manager for Nutrition, Physical activity and Obesity at the WHO Regional Office for Europe, responsible for the implementation of the European Food and Nutrition Action Plan 2015-2020 and the Physical Activity Strategy for the WHO European Region 2016-2025, as well as evaluating their implementation process.

Dr. Breda was also the recipient of the Gold Medal for outstanding services in the field of Health granted by the Portuguese Ministry of Health in 2018. He also received more than 20 scientific and academic awards and/or distinctions notably the Honorary Professorship by the Medical Academy of Kazakhstan and the Gerlev Award (Denmark). João Breda has published more than 250 original reports, scientific articles and more than 20 books (including the number one best seller on infant nutrition in Portugal),

Before joining WHO, Dr Breda was the Portuguese focal point to WHO/Europe for alcohol, nutrition and physical activity, and to the High-Level Group on Nutrition & Physical Activity and the European Platform on Diet, Nutrition and Physical Activity of the European Union.

He was the first coordinator of the national platform against obesity under the Portuguese Ministry of Health. He worked as a public health official at the general Health Directorate of Health for many years. He was the Head of the Nutrition Department at Atlantic University in Lisbon as well as lecturer and researcher at the Agriculture University of Coimbra (ESAC), the University of the Algarve and the School of Hospitality and Culinary Arts in Coimbra.

Dr João Breda is a PhD in Nutrition with a focus on public health, a Master of Business Administration, a Master’s in public health and initially graduated in Nutritional Sciences.

Theodore E. Tryfon was born in Mytilini – Lesvos. He graduated from Athens College of Greece and earned his BSc in Economics and Business Administration from the University of Southampton in UK. He continued his studies by earning his MBA from the City University of London Business School.

In 1990 he joined Henkel Hellas, Tryfon – Kastrinis S.A., a family owned business, which was sold to Henkel Germany in 1992.

The ELPEN Group has a turnover of €250,000,000 in 2021, with over 1200 employees and 3 production units in Pikermi, Attica. In November, the new 12,000 m2  production unit in Keratea Attica will operate mainly with an export orientation. ELPEN holds a leading position in the drug market, exports to 40 countries and has the largest Research, Training and Experimental Center for the Pharmaceutical Industry in Greece.

He is currently the President of the Panhellenic Union of Pharmaceutical Industries (PEF) since 2014, an association which represents 45 companies with 28 production sites throughout Greece. Since April 2019 he is a Member of the Board of Hellenic Federation of Enterprises (SEV). In 2019 he became a member of the Board of Directors of Medicines for Europe, the European Association, which represents the European generic and value added medicines industry as a whole.

Dr. Evangelos Manolopoulos recently assumed the duties of president of the National Pharmaceutical Organization (EOF). He is a Professor of Pharmacology, Pharmacogenomics and Precision Medicine at the Department of Medicine of the Democritus University of Thrace (DPTH) in Alexandroupolis and at the same time offers his services at the University General Hospital of Alexandroupolis. He graduated from the Patision Lyceum of Leon in 1979. He received a BA in Biology in 1984 and a PhD in Pharmacology from the Medical School of the University of Patras in 1992. He also worked for almost a year at the Medical School of the University of Groningen, The Netherlands (1989-1990). Between 1992 and 1995 he did postdoctoral research at the University of Wisconsin Medical School in the USA. He then worked for 3 years (1995-98) at the Medical School of the Catholic University of Louvain in Belgium. Since December 1998 Dr. Manolopoulos is a member of the Faculty of Medicine Thrace. He has authored over 150 foreign language publications in peer-reviewed journals, including two in the New England Journal of Medicine, which have received a total of more than 4600 citations (H factor 36). His current research interests focus on personalized and precision medicine and include basic, translational and clinical research in pharmacogenomic and epigenetic analysis of drugs used in cardiac disease, anticoagulation, diabetes, oncology and psychiatric diseases. He has received a total of over 3 million euros in competitive funding for his research. Also, Mr. Manolopoulos has a diverse academic work while he is, among others:

– Head of the Unit for Therapeutic Measurement of Drugs and Prohibited Substances of the University General Hospital of Alexandroupolis (PGNA).

– Director of the “Clinical Pharmacology and Therapeutics” Master’s Program of the ITH, which was founded in 2006.

– Director and Scientific Officer of the “Center of Excellence for Pharmacological Studies and Precision Medicine” (IMPReS) of the ITH.

– Member of the Board of the Hellenic Society of Basic and Clinical Pharmacology (where he has also served as president 2017-2021)

– Past president of the European Society for Pharmacogenomics and Personalized Therapy (ESPT) (was president 2020-2022)

– Representative of Greece in the European Association of Clinical Pharmacology and Therapeutics (EACPT) continuously for the last 12 years.

– Member of the Editorial Board of: British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Pharmacogenomics

– Evaluator of collaborative research proposals submitted to the European Union (2007 – 2022) and several other Greek and international organizations over the last 20 years.

– During the SARS-CoV2 pandemic, Dr. Manolopoulos focused his attention on the study of the coronavirus and monitoring the relevant developments. In fact, he has already published 3 papers on possible ways of early diagnosis and pharmacological treatment of this modern scourge, while throughout the pandemic he fought every day to properly inform the public about vaccines and anti-pandemic drugs through dozens of television and radio interviews and articles in newspapers.

Nikos Dedes is Chair of Positive Voice, the Greek Association of People Living with HIV and Chair of the Greek Patients’ Association. He has a longstanding involvement in European organisations and initiatives and is currently member of the Steering Committee of NEAT id (European Treatment Network of HIV, Hepatitis and Global Infectious Diseases). He is a member of the HIV Treatment Guidelines Panel of EACS (European AIDS Clinical Society), a member of the Steering Committee of the “HIV Outcomes” and “EuroTEST” initiatives and BoD Member of the European Patients’ Forum (EPF). 

He has been past chair of the European AIDS Treatment Group (EATG), past member of the Management Board of the European Medicines Agency (EMA) and past member of the WHO Strategic and Technical Advisory Committee on HIV. Nikos advocates for universal access to evidence-based and cost-effective care and prevention services for all people as a moral imperative and pre-condition for a prosperous and fair society.

Kostas Athanasakis, Economist specializing in Health, is Assistant Professor of Health Economics and Economic Evaluation of Health Technologies at the Department of Public Health Policy, School of Public Health, University of West Attica.

His main subject, teaching and research, is the Evaluation of Health Technologies, the Economic Evaluation of health interventions, Pharmacoeconomics and Drug Policy. In addition to the above, his research interests also extend to the financing of health systems, the economic analysis of health markets and public finance. He is the author of more than 250 articles and abstracts in international and national journals as well as 14 books, in the broader field of health research, economics and policy.

He is a member, among others, of the KESY Steering Committee, the Public Health Expert Committee, the National Immunization Committee (NEC) and the Expert Group on the coronavirus pandemic (COVID-19) of the National Bioethics Committee (NEC). He has been Chairman of the Research Review Committee of the 17th and 18th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Consultant – External Researcher of the World Bank and ECDC.

He is also Associate Editor of the International Journal of Technology Assessment in Health Care (IJTAHC) (Cambridge University Press).

Before assuming the new General Secretariat of Strategic Planning, Dr. Aris Aggelis was Assistant Professor of Health Economics in the Department of Health Services Research and Policy at the London School of Hygiene and Tropical Medicine (LSHTM). From this position, among other things, he had undertaken the development of a research program aimed at evaluating new oncology products at an early stage using pharmaco-economic and decision analysis techniques, with the support of the English organization Health Technology Assessment (HTA), National Institute for Health and Care Excellence (NICE).

Prior to joining LSHTM, he worked as a researcher and visiting professor in the Department of Health Policy at the London School of Economics and Political Science (LSE), where he remains a visiting researcher. At LSE, he most recently participated in the European Commission-funded Impact-HTA project, where he led the research activities of a work package on Multiple Criteria Decision Analysis methods in drug evaluation in collaboration with national HTA bodies. He also directed a research program of the European Society for Medical Oncology, for the development of a framework for the evaluation of anticancer drugs.

Dr. Aggelis holds a PhD in Health Economics and Policy from LSE. He also holds an MSc in International Health Policy from the LSE, an MSc in Biopharmaceutics from King’s College London and a BSc in Biochemistry from Imperial College London.

To date, he has worked as a researcher, consultant and trainer in numerous research programs of the European Commission, the World Health Organization and various national Ministries of Health. He has published numerous research articles and studies in leading international scientific journals.

Theodoros Skilakakis was born in 1966, graduated from the Varvakeio Standard School in 1984 and then from the School of Pharmacy of NKUA in 1990.

In 1993 he founded the PROPHARM pharmacy and then the PROFARM group of companies (PROFARM S A, EL-PHARM S A, PHARMAGROUP ARGOUS S A, PHARMAGROUP MESSINIAS S A, PHARMAGROUP AXAIAS S A, INTEGRIS PHARMA S A, PERSE PHARMA SA, MEDWORLD S A) in 2009 (today the group owns a majority in eight companies in the field of distribution and trading of Pharmaceuticals and is the strongest Private group in the country with 400 employees and a turnover of 280 million euros).

He was elected for the first time to the Board of Directors of the Association in 2010 and became its secretary in 2014 and president in 2023

Dr Irene Agapidaki is a Psychologist, with a Master’s Degree (MSc) in Health Promotion and Education from the Medical School of the National and Kapodistrian University of Athens and a PhD in Health Psychology from the same School, while she has retrained and in matters of prevention of mental disorders and promotion of mental health. In addition, she has many years of teaching and research experience in the fields of public health policy making, Public Health research methodology and mental health promotion, in the context of national, European and international research programs.

She worked as a research associate for a number of years at the Laboratory of Hygiene, Epidemiology and Medical Statistics of the Medical School of Athens, while in the recent past, she was elected and served as a Public Health Lecturer at the Medical School of the European University of Cyprus. She has written and published research papers in peer-reviewed scientific journals, while she has presented the results of her research papers at many Greek and international conferences.

In 2019, she resigned from her academic position in order to take up the duties of the Special Secretary for the Protection of Unaccompanied Minors at the Ministry of Immigration and Asylum, where she remained until 2022. During her tenure at the Special Secretariat for Unaccompanied Minors, all unaccompanied minors were transferred from the Centers Reception and Identification of the islands and Evros, more than 2000 children in total, in suitable accommodation structures inland and in other K-M through the relocation program as well as the reunifications, the framework for age assessment was improved to ensure that those who placed in child protection structures are indeed minors, protective custody by law was abolished, a shameful practice that our country has been following for twenty years with condemnations from the European Court and strict recommendations from the Council of Europe, and the national mechanism for early locating & hosting unaccompanied minors who are found homeless, throughout the territory. This mechanism is an important means of preventing the disappearance of minors and is something that our country should have implemented years ago. In addition, the places in suitable long-term accommodation structures increased and thus we finally managed to have 2000 places in such structures, a goal that our country already had in 2017 and, of course, a relocation program for unaccompanied minors to other EU Member States was implemented in cooperation with International Organizations and the European Commission, immediately ensuring effective protection (more than 1300 unaccompanied minors and 1024 persons were resettled of which 612 were seriously ill children together with their nuclear family members in Germany). Thus, from the over 5,500 unaccompanied minors recorded in our country in 2019, we now have a stable number that does not exceed 2,500, ensuring effective protection.

At the end of December 2022, she assumed the duties of Secretary General of Public Health, implementing, among other things: the pediatric digital child book, so that our country can finally have, for the first time, official and reliable data on the vaccination coverage of children, while at the same time extensive vaccinations were organized and implemented in vulnerable population groups. In addition, the new “Spyros Doxiadis” Prevention of the main chronic diseases, Protection and Health Promotion plan was developed, which includes over 20 primary, secondary and tertiary prevention actions with a budget of over 300 million euros, which are the first effort in history of our country for an organized and systematic prevention system for the entire population. Indicatively, the actions concern prevention programs of the main risk factors such as the prevention and fight against childhood obesity in children and adults. At the level of secondary prevention, the “Fofi Gennimata” program is already being implemented, thanks to which more than 120,000 digital mammograms have already been performed and more than 7,500 women have been identified in time with findings. Next comes the cervical cancer prevention program, for 2.5 million women aged 21-65 with free screening tests-pap, HPV-DNA test, colposcopy and biopsy, the colon cancer prevention program , for 3.8 million men and women, aged 50-70 with a free colonoscopy examination, the cardiovascular disease prevention program, for 5.5 million women and men aged 30-70 with free lipid profile blood tests and early detection of cardiovascular disease
risk and metabolic syndrome, but also the lung cancer prevention program in people at high risk, as well as the skin cancer prevention program in high-risk groups.

Dimitris Demos was born in Athens, Greece, and holds a degree in Chemistry from the University of Athens and an MBA in Finance from Fordham University in New York. Following his studies, he joined the family business of DEMO S.A. Pharmaceutical Industry working in various positions, applying his business vision in practice.

Today, Dimitris Demos is the CEO of DEMO SA, one of the largest manufacturers of injectables in Europe, with an annual turnover of €250 million, 4 state-of-the-art production units of 66,000 sq.m. and more than 1,300 employees. The company heavily invests in production and exports, which is why DEMO exports 80% of its annual production to 86 countries around the world, while, with the remaining 20% sold in Greece, it is the biggest supplier, in terms of units, of the Greek Hospitals. DEMO S.A. has over 3,200 SKUs sold under its own brand and 619 SKUs that are in the process of being licensed.

With its new investment plan of over €350 million for the period 2021-2027, DEMO is implementing more than 25% of the total investments of the pharmaceutical sector in Greece.

Mr. Dimitris Demos is also Vice President of the Panhellenic Union of the Pharmaceutical Industry, which represents the collective domestic pharmaceutical production in Greece.

Nikos Papathanasis is the Alternate Minister of National Economy and Finance and Member of Parliament B1 North Sector of Athens with New Democracy.

He is a mechanical engineer, a member of the TEE and has received postgraduate degrees in Business Administration and Aeronautics.

He started his working life in 1984 in the aeronautical industry, while he has been a member of the Boards of Directors of private sector companies as well as public interest companies such as the Hellenic Aviation Industry (EAB), Olympic Aviation and urban railway companies such as H.S. A.P. and ST.SY.

He worked for twenty-four years in senior and then top management positions in private sector companies and eight years in top management positions in wider public sector companies.

He was the President of the Center of Greek Public Enterprises and Organizations of Public Interest (KEDEO) and is the President of the scientific non-profit company “Institute of Democracy Konstantinos Karamanlis”.

In 2016, by the decision of the President of New Democracy Mr. Kyriakos Mitsotakis, he assumed the General Directorate of the party.

In 2019 he was appointed Deputy Minister of Development and Investments responsible for Industry and Trade, while in 2020 he was appointed Deputy Minister of Development and Investments responsible for Private and Strategic Investments as well as Public and Private Sector Partnerships.

She is a political scientist – internationalist, with postgraduate studies in European Politics and Administration at Panteion University.

She specializes in strategic planning and reforms, with an emphasis on the economic and market sectors.

She has extensive and extensive experience in public administration, having served in positions of responsibility successively in the Ministry of Defense, the Ministry of Education and the Ministry of Development. Especially at the Ministry of Development (2012-2015) she was responsible for monitoring and coordinating all market reforms as well as cooperation with the European Union and International Organizations, such as the OECD and the World Bank.

She was Deputy Secretary of Strategic Planning and Communication of New Democracy since January 2016.

In October 2017, she was appointed adviser to the President of the New Republic on health issues.

In the national elections of 2019, she was included in the State ballot of the New Democracy in an honorary position.

In the summer of 2019, she assumed the position of General Secretary for the Coordination of Economic and Development Policies at the Presidency of the Government and then, from August 2020, she was the General Secretary of Tourism Policy and Development of the Ministry of Tourism.

In December 2022, she was appointed Secretary General of International Economic Relations and Outreach of the Ministry of Foreign Affairs and Chairman of the Board of Enterprise Greece with a task both in promoting exports and attracting investments with an emphasis on strategic investments.

From July 25, 2023, she is the General Secretary of Private Investments at the Ministry of Development.

Lilian Venetia Vildiridis is an Economist specializing in Health policy, planning and financing.

Graduate of the London School of Economics and Political Science (BSc in Social Policy and Economics) and holder of a master’s degree (MSc in Health Policy, Planning and Financing) from the London School of Economics and Political Science and the London School of Hygiene and Tropical Medicine , is a PhD candidate at the School of Health Sciences of the National and Kapodistrian University of Athens.

She was the Director of the special office of the Deputy Minister of Health Asimina Gaga (February 2022 – May 2023) and of the acting Minister of Health Anastasia Kotanidou (June 2023), adviser to the Deputy Minister of Health Asimina Gaga (September 2021 – January 2022), as well as an adviser to the Deputy Minister of Health Vasilis Kontozamanis (July 2019 – August 2021).

She has also been Coordinator of the organization for monitoring and accelerating the implementation of the actions and projects of the Recovery and Resilience Fund, which fall under the competence of the Ministry of Health, and President of the Monitoring Committee for the implementation of the project “Renovations and Modernization of Hospitals throughout Greece » of the Recovery and Resilience Fund. In 2020, a representative of Greece was appointed to the Board of Directors of the European Commission for the joint supply of vaccines and treatments against the disease COVID-19.

She has worked as a research fellow at the LSE Health and Social Care Research Center – London School of Economics and Political Science.

Her research interests focus, among others, on Health policy related to health care systems, with a particular emphasis on their performance assessment (HSPA), on the development of tools for the execution of planning and the management of human resources in Health (Health Workforce), in the formulation of indicators to measure the outcomes and experiences of patients receiving health services, as well as in policies that ensure equal access to health care services.

She has published research articles in international journals.

Ms. Karpodini has studied Business Administration with a specialization in accounting and finance at the Athens University of Economics and Business and holds a Master’s degree in Business Administration.

She has seventeen years of management experience, both in the private sector as a senior business executive, and in public administration for the last ten years as a special advisor to the General Accountant of the State of the Ministry of Finance.

In her professional career, she has been involved in the financial control of SAs, balance sheets-accounts of public bodies, while she was responsible for the Debt Repayment Program of General Government Bodies 2012-2014 as a special advisor to the GLC.

Founder, President and CEO of CORONIS Research SA since 2003.

Evangelia Koraki studied Chemistry at the University of Athens. She has more than 15 years of expertise and management experience in the field of Medical & Regulatory Affairs in global pharmaceutical companies such as Roche, Warner Lambert, Pfizer, Actelion Pharmaceuticals, and 20 years in senior positions in clinical research. She has contributed to the development of numerous products, including orphan drugs, in international markets, and has deep knowledge of regulatory affairs processes at a national, European and international level. She participates in many working groups relevant to clinical research in Greece, with the aim of promoting and harmonizing it with European standards.

She has been a founding member and a Member of the Board of Directors of the Hellenic Association of CROs – HACRO, since its establishment in 2013. In 2017, she was elected as President of HACRO and holds this position to this day.

Dr. Panagiotis Kalafatas is the Founder, President & CEO of KALTEQ SA since 2004.

He owns a long experience in the field of Healthcare for more than 30 years, initially as an executive in well-known multinational companies and then as an Entrepreneur and Founder of KALTEQ for the last 20 years.

He is dedicated to Business, with the passion of turning innovative ideas into tangible and successful results. He has extensive experience in formulating and executing strategic plans, creating new business opportunities and business development.

His career includes many successful business ventures and collaborations with leading groups of professionals that were the main ingredient for the successful course of his company, but also the basis for the further development of his business plans.

With a keen eye to the Future, Dr. Kalafatas is the source of inspiration for his Team and aims even higher in the development of his company and its potential, constantly creating opportunities and new business plans.

Alexandros Sarrigeorgiou is President & CEO of the Eurolife FFH Insurance group.

He is the Chairman of the Board of Directors of the Association of Insurance Companies of Greece, Vice-Chairman of Insurance Europe, member of the Advisory Board of A.M. Nomikos Transworld Maritime Agencies S.A and member of the Executive Board for Europe, Middle East and Africa of the Wharton School, University of Pennsylvania. He is also the Chairman of the Hellenic Advisory Board of South East European Studies at Oxford (SEESOX), a member of the Board of Directors, the Executive Committee and the Investment Committee of the Foundation for Economic and Industrial Research (IOBE) as well as a member of the General Council of the Business & Industries Association (BSE). He is also Vice President of the Board of Directors of the Wharton Club of Greece.

Among other Boards of Directors, he has been a member of the Board of Directors of S&B Industrial Minerals Holdings S.A.R.L. , of the Capital Market Commission and the Hellenic Institute of Insurance Studies (EIAS) and member of the Board of Directors of Grivalia Hospitality S.A.

Mr. Sarrigeorgiou holds an MBA in Finance from the Wharton School of the University of Pennsylvania and an MSc and BSc in Civil Engineering from Columbia University.

In the past he has worked in large financial groups in Greece and the USA.

He is a graduate of the School of Medicine of the University of Athens specializing in neurosurgery, holds a doctorate from the School of Medicine of the University of Athens and a master’s degree in Health Unit Management.

In June 2023, he was sworn in as Deputy Minister of Health.

He was Secretary General of Primary Care at the Ministry of Health from 2020 to 2023 and Coordinator of the Vaccination Program against Covid-19 “Operation Freedom”.

He has served as President of the National Central Health Procurement Authority, member of the Coordination and Monitoring Committee of the Government Policy to deal with the Covid-19 pandemic, President of the Management Committee of the Health Insurance Sector (formerly TSAY – Health Insurance and Pension Fund) and Vice President of the Administrative Board Board of the ETAA (Unified Fund of Independent Employees).

As a neurosurgeon he worked in hospitals of the United Kingdom, in G.N. “Evangelism” and as Curator 1 at the Neurosurgery Clinic of the Children’s Hospital “St. Sophia”.

Dr. Vassilis Apostolopoulos is the CEO of the Athens Medical Group, which is the leading company in the health sector in Greece and Southeast Europe. At the same time, Dr. Apostolopoulos is CEO of the family Holding (G. Apostolopoulos Holdings S.A.)

Dr. B. Apostolopoulos is Honorary President of the Hellenic Business Association (EENE) which he chaired from 2012 to 2022, member of the Advisory Board of the Hellenic Observatory of the London School of Economics, President of the Hellenic Association of LSE Alumni (HAALSE), member of the Administrative Board Council of the “Athenian Club”, the most historic club in Greece.

In 2020 he was awarded the “Lifetime Achievement Award” of the British Council, which was given to a Greek for the first time. For his business activity, he was distinguished in the context of the EY “Entrepreneur of the Year” competition in February 2022 as Pioneering Entrepreneur of the year 2021.

He is married to Roi Danalis and father of four children.

President EINAP

Chairman of the Board of Directors Society of Pathology of Greece (E.P.E.)

Coordinator Director of the 3rd Pathology Clinic, G.N.A. “C. birth”
Scientific Manager of the Lipid Clinic, G.N.A. “C. birth”
President of the Scientific Council G.N.A. “C. birth”
President of the Supreme Disciplinary P.I.S.
Vice President of OENGE

MEDICAL SERVICE
First Experience in Hospitals, clinics, etc.
1) From 21-04-83 to 20-04-84 in G. N. Limnos (ND 67/68 Field Service)
2) From 02-05-84 to 09-07-84 in G. N. Limnos (Law 1057/80)
3) From 09-07-84 to 15-01-85 in G. N. Limnos (Obtaining specialty)
4) From 22-01-85 to 19-12-88 at G.N. A. “ELPIS” (Obtaining a specialty)
5) From 08-12-89 to 13-05-93 at G. N. A. “ELPIS” as Supervisor of the 2nd Social Security
6) From 14-05-93 to 28-10-98 at G.N.A. “G.Gennimatas” as Editor. B’ SYSY
7) From 29-10-98 to 04-04-06 at G.N.A. “G. Gennimatas” as Editor. A. YOU
8) From 04-04-06 to 01-12-08 at G.N.A. “G. Gennimatas” as Assistant.
Director (Prot. No. Y10a/13335/4-4-2006 Dep. Ministry of Health & Social Affairs)
9) From 01-12-08 Director of the 3rd Pathology. Clinic of G.NA “G. Gennimatas”

CURRENT POSITION
Professor – Director, Neurosurgery Clinic, EKPA, Evangelismos
Laboratory of Neurosurgical Anatomy, Evangelismos
Hellenic Center for NHK Research, Professor P. Kokkalis, Evangelismos
Treasurer of the Hellenic Neurosurgery Society (2013 – 2023)

VISITING PROFESSOR
The Royal College of Surgeons of Edinburgh, UK

COMMITTEES
President of the Examining Committee of Neurosurgery Specialty (2020 – )
Neurosurgery Coordinator, Central Health Board (2023 – )
President of the Stereotactic Radiosurgery Committee of AUS (2019 – )
Appeals Committee of the Ministry of Higher Education Health (2015 – )
Trauma Management Organization Committee of the Ministry of Health (2020 – )
Committee on Implantable Systems Min. Health (2015 – )

PREVIOUS POSITIONS
Associate Professor NHK Clinic, EKPA, Evangelismos, 2011 – 2017
Assistant Professor NHK Clinic, EKPA, Evangelismos, 2004 – 2011
Supervising Neurosurgeon, NHK Clinic, Evangelismos, 1996 – 2004
Supervising Neurosurgeon, Hygeia Hospital, 1992 – 1995

POST-GRADUATE EDUCATION
Research Specialist, MGH, Harvard Medical School, Boston, USA, 1991 – 1992
Curator, Frenchay Hospital, Bristol, UK, 1989 – 1991
Curator, AMH, Saint George’s Medical School, London, UK, 1988

SPECIALTY
Resident, Neurosurgery Clinic, Evangelismos, 1984 – 1988
Resident, Neurology Clinic, Children’s Hospital, 1983 – 1984
Resident, Department of Surgery, Children’s Hospital, 1983
Resident, Surgery Clinic, GN Corfu, GN Florina, 1981 – 1982

EDUCATION
Doctoral Dissertation, School of Medicine, EKPA, 1994
BA in Psychology, American College of Athens, 1988
Medical School Degree, EKPA, 1981
High school diploma, Moraitis School, 1975

PROFESSIONAL ORGANIZATIONS
European Association of Neurosurgical Societies (EANS), 1993
Hellenic Society of Neurosurgery, 1993
American Association of Neurological Surgeons (AANS), 1993
Society of British Neurological Surgeons (SBNS), 1993

INTERESTS
Neuro-Oncology, Neuro-Anatomy, Hydrocephalus, Neuro-Intensivist,
Neurotrauma, Hemorrhagic Vascular Stroke,
Neuroepidemiology, History of Neurosurgery, Human Resource Management.

Anargyros Souliotis has a long experience in the field of Business, initially as an executive in large multinational companies and then as an Entrepreneur and CEO of a group of companies dealing in the field of health, construction of private and public projects, transport, and advertising.

What characterizes him is acumen and foresight, the persistence and determination to achieve the goals he has set in each of his business plans. Looking to the future, Mr. Souliotis is a source of inspiration for his team and also for his family who are active with him in their business group.

His goal is with the company HELLENIC COPPER to reach even higher the development of the company and its dynamics. It makes him particularly proud that through the application of the company’s products in health care areas, Public Health is defended as a whole and gives undivided priority to the protection of human life.

He has also been awarded for his philanthropic work in the field of Health through numerous donations to the National Health System (NHS) as a whole.

Mr. Aris Apostolou has graduated from Athens College. He holds a degree from the Department of Industrial Management and Technology of University of Piraeus and a master’s degree in Business Administration – Total Quality Management (TQM) from the same University. 

He has a 20-year working experience in private and public sector. During these years he held managerial positions in supply chain management as well as in finance. In private sector, he worked for the companies ANEK LINES, IKEA, Grigoris micro-geymata. From 2019 to 2021, he served as an Executive Manager to the Board of Directors of ELLINIKO SA, until the transferring of the shares and the initiation of the project from LAMDA Development SA. In the past he was placed as a senior advisor to Ministers of Health, and he was mainly responsible for reducing the arrears of both the Hospitals and the National Organization of Health Services. Also, he was preoccupied with the reorganization of the supply chain and more. Furthermore, he was appointed as a Deputy Governor of the 1st Health Region and a member of the Board of Directors of IDIKA SA representing the Ministry of Health.

Since May 2022, he is the President of the National Centralized Health Procurement Authority. 

Professional Experience

• 2019 / September, Commander of the 1st Health Region of Attica.
  (Posted on 25/9/19, after a Decision of the Minister of Health B. Kikilia).
• 2014-2015/ March, Commander of the Attica Security Directorate.
• 2012-2014, Commander of the Hellenic Internal Affairs Service Police. (Selection after evaluation and with the agreement of the Institutions and Transparency Committee of the Parliament).
• 2009 -2012, Deputy Commander of the Internal Affairs Service of the Hellenic Police.
• 2008-2009, Press Representative of the Hellenic Police Headquarters (2nd term under the ministry of Professor P. Pavlopoulos).
• 2007-2008, Staff Officer of the Headquarters of the Hellenic Police/ Directorate of Police Personnel.
• 2006-2007, Press Representative of the Ministry of Public Order/Hellenic Police Headquarters (1st term, during the ministry of B. Polydora).
• 2005 -2006, Department Head of the 1st Personnel Department, Attica Security Directorate.
• 1999 – 2005, Head of Department of the Administrative Support Department, Internal Affairs Service of the Hellenic Police (Founding member of the Service, which was established in 1999 by law 2713/1999 and started operating from 26/10/1999).
• 1997 -1999, Head of the Office of Operations – Policing, Internal Operations Department of the Attica Security Directorate.
• 1992 -1997, Head of the Law Enforcement Office, General Policing Department, Athens Police Department.
• 1989 -1992, Military Officer in the Police. Department of St. Spyridonos Egaleo.
• 1986 -1989, Probationary Officer at the School of Officers of the Hellenic Police (SAEA).

Education and training

• 2007, Postdoctoral studies, Department of Criminology, Panteion University, Athens.
• 1999, Doctoral Diploma (Ph. D), Panteion University. Athena.
• 1994, Degree in Sociology, Panteion University. Athena.
• 2001, Diploma, School of Continuing Education and Training of the Greek Police / Department of Professional Continuing Education of Executives.
• 1989, Graduated from the Greek Police Officers School

Dr. Thanassis Lopatatzidis holds a PhD (Bristol University) in Health Services Research, Statistics & Management & an MSc in Actuarial Statistics (University of Sheffield). He was Project Manager – Research Associate (1993 -96) & then Lecturer in Bristol University (1997 – 02). 

In Greece worked as Managing Director of a Reengineering program (1999 -2004) for the Social Security Sickness Fund (namely IKA), and then as an external consultant in UK for a joint venture between CAS Services ltd & AXA insurance for NHS Direct. At the end of 2007 joins the leading primary healthcare provider in Greece (BioMedicine Group) as a General Manager responsible for commercial function and key operational excellence, engaging with Private Health Insurance developing & managing several new and innovative business lines, digital tools and reimbursement policies.

In Oct 2016 joined Affidea, a leading European outpatient care provider and now as a Commercial Director is leading the deployment of Affidea’s outpatient & commercial B2B strategy including the engagement & commercial excellence together with Private Health Insurers the Pharmaceutical Industry and other commercial partners. Contributing to a significant extent in the organic growth of the company.

He has a robust 25 years of expertise in the healthcare industry.

Dr. Lopatatzidis has been an invited speaker in several national & international conferences & workshops. His scientific & managerial work includes more than 55 national & international programs & studies. He has published 2 books & more than 30 articles & book chapters in peer review journals & books. He is fellow or member in several scientific or professional bodies such as Fellow of the Royal Statistical Society (Actuarial Chapter), Member of the International Society for Health Technology Assessment, Hellenic Health Managers Association etc.

Vassilis is the Chief Executive Officer of the National Organisation for Quality Assurance in Health (ODIPY S.A.) and lecturer of Quality Improvement, Healthcare & Pharmaceutical Policy at SDA Bocconi in Milan.

Prior to joining ODIPY, Vassilis was the Healthcare & Life Sciences Strategy Consulting Lead for Deloitte in Greece. Vassilis served in senior roles in the UK’s NHS (in London and across England) for several years where he designed and led hospital acquisitions and large-scale operational transformations.

Vassilis holds 3 Masters Degrees: (a) International Healthcare Management, Economics and Policy, (b) Master in Business (c) Telemedicine & E-Health Systems.

PROFESSIONAL EXPERIENCE

• December 2013 – Present | Joint Governor of the Interconnected Hospitals  G.N.P. ATHENS  ” HAIA SOFIA ” G.N.P. OF ATHENS ” P. & A. KYRIAKOU “
• October 2011 – December 2013 | Joint Governor of the Interconnected Hospitals G.N.P. OF ATHENS “AGIA SOFIA – CHILDREN’S PENDELIS” G.N.P. OF ATHENS « P & A KYRIAKOU »
• March 2010 – October 2011 | Commander G.N.P. ATHENS “HAIA SOFIA”
• December 2005 – March 2010 | General Manager  Athens Medical Group – Peristeri Clinic
• June 2005 – December 2005 | Head of Administrative Care BIOMEDICINE International Diagnostic Laboratories
• May 2002 – October 2004 | Deputy Governor  G.N. ATHENS “HIPPOKRATEO”
• October 2000 – May 2002 | Advisor to the Minister of Health, Ministry of Health
• October 1999–September 2000 | Advisor to the President G.N. ATHENS “THE EVANGELISM”
• October 1996–September 1997 | Assistant General Manager Bury Health Care NHS Trust Fairfield General Hospital

PROFESSIONAL TRAINING

• September 1994–November 1995 | Master of Arts in Hospital Management, Nuffield Institute of Health, University of Leeds
• September 1991 – July 1994 | BA Combined Honors Health Studies & Management Science, University of Central Lancashire

Nikos is Professor of health management and policy at the School of Public Health of the University of West Attica, where he served as an Alternate Dean and MSc program director for several tenures. Presently serves as board member in several life sciences firms in Greece, UK, and the USA, leading their corporate development through business innovation and operational transformation.

In the past he served directorships at leading pharmaceutical, consulting, and health provision organizations and was fellow at the universities of Oxford and Warwick. He acted as advisor to many private and public organizations and devised strategies and policies in many countries worldwide.

He is an international public speaker, top-ranked author, and editorial board member of two leading academic health journals. Trained in economics and management at the University of York and Warwick Business School, and in business innovation at Harvard Business School and INSEAD.

Dimitris Vassilopoulos holds a degree in Electrical Engineering from the National Technical University of Athens and a Master of Science degree in Digital Communications from King’s College London (University of London), as well as postgraduate degrees in Business Administration from the Hellenic Society of Business Administration and in Project Management (PMP) from the Project Management Institute.

From February 1996 to January 2003 he worked for BULL S.A., the Greek subsidiary of the French Groupe Bull, as Project Manager in the Integrated Project Division and subsequently as the Marketing & Business Development Manager determining solutions and partnerships in the verticals of Public Finance. 

In February 2003 he moved to the Business Development Dept. of Public Sector Division for Intracom/Intrasoft Group, undertaking the role of the Commercial Manager for the Greek Public Sector vertical markets of Health, Social Security and Public Finance, while since 2008 his role upgraded taking the responsibility as Business Development & Sales Director for all vertical domains of the Public Sector market in the geography of Europe, Middle East & Africa. 

As of 1/1/2019, by undertaking the role of Marketing & Sales Senior Director of Netcompany-Intrasoft he focused on the Product Management & Marketing of the business-specific Tax, Customs, Social Security and Compliance Products, as well as their market positioning, in close cooperation with Netcompany Group teams, upon the acquisition of Netcompany-Intrasoft.

In early 2023 he assumed the duties of Executive Director of the Public Sector Business Unit, being mandated to secure its operational performance and continuous growth, while strategizing for the adoption of innovative and differentiating new business and technical competencies, for the expansion into new markets sectors and countries/geographies and for the strengthening of its human capacity force with continuous qualification upgrade.

She is a graduate of the Medical School of the University of Athens with specialization in Pediatrics and specialization in Infectious Diseases. She holds a PhD from the School of Medicine of the University of Athens and a degree in Radiology from the TEI of Athens.

Work experience

• Coordinator Director at the First Pediatric Clinic, “Agia Sophia” Children’s Hospital (2023)
• Pediatrician – Infectious disease specialist, supervisor A’ at the A’ Pediatric clinic of the University of Athens, “Agia Sophia” Children’s Hospital. (2013- 2023)
• Specialist in pediatrics at the First Pediatric Clinic of the University of Athens, “Agia Sophia” Children’s Hospital. (2007-2011)
• Radiology radiology technologist in its CT department, GNNTHA “Salvation”. (2002 – 2007 and 2011-2013)

She actively participates in scientific events and clinical studies. She is the author of several publications and a lecturer in graduate and undergraduate programs.

She was a representative of the “Agia Sophia” Children’s Hospital at the EDNYPY, a member of the “Agia Sophia” Children’s COVID19 Management Team, a member of the committee for introducing protocols and supervising the treatment of pediatric patients with COVID19 in the Children’s hospitals of the 1st HYP, a member of the acute management committee hepatitis of unknown etiology.

She is a member of the Infections Committee, the OEKOHA Committee, the Medicines Committee and the Scientific Council of the “Agia Sophia” Children’s Hospital.

She participates as a member of the editorial team of scientific journals, the organizational and scientific committee of conferences and the Ethics and Ethics committee of the Children’s Health Institute.

She is a member of scientific organizations such as the European Society Pediatric Infectious Diseases (ESPID), the Hellenic Society of Infectious Diseases, the Hellenic Society of Pediatric Infectious Diseases (ELEPL), the Scientific Organization of Children and Adolescent Health (E.O.Y.P.E.).

Τheodoros Chamakiotis was born οn 1975 and he was graduated from the School of Public Administration and Economics of TEI Athens University with studies in the Management of Health and Welfare Units. He holds a master’s degree (MSc) in Health Unit Management of Social Sciences Department of the Hellenic Open University.

He has more than 20 years of experience in Health Care Providers, holding positions of Management as well as positions of responsibility in the subjects of Finance and Management. He belongs to the Athens Medical Group workforce from 2009 as General Manager of Athens Medical Center – Phychiko Clinic. Since 2019, he is the General Manager in Athens Medical Center.

He is a member of the Board of Directors of the Hellenic Private Hospitals Association (HPHA) and in October 2021 was elected as President.

He is the co-founder and Quality Assurance Director of the certification and audit body HEALTHCERT.

He is a graduate of the School of Chemical Engineering of the National Technical University of Metsov, holder of a PhD in Chemical Sciences from the School of Chemical Engineering of the National Technical University of Athens and a master’s degree in Oenology and Viticulture from the Agricultural University of Athens.

He has worked as a Chief Inspector of Management Systems and Products since 2015 in national and international certification bodies with a wide inspection scope and with experience in the Development and Accreditation of bodies and Certification Schemes and as a Production and Quality Manager in manufacturers of Medical Technology and Diagnostic Products.

Nikos Chatzinikolaou was born on October the 9th 1962, in Alexandroupolis, Evros. He started working as a journalist in 1983 covering education topics in the newspaper “MESIMVRINI”.

In 1984, he received the “Botsi” award for journalism. He then started to cover political issues. Meanwhile, he started his collaboration with the Sunday edition of the newspaper “Akropolis”, the newspaper “Ethnos” and the magazines “ENA” and “STATUS”.

In 1987, he started working for the newly founded radio “ATHINA 9,84”. At the same time he became member of the founding committee of the station. He also temporarily worked at the radio stations “ERA”, “SKY 100,4”, “PLANET” and “STATUS FM”.

In 1989, he started his collaboration with MEGA TV station. From 1998 until 2003 he was General Director of News and Information department of the station.

From 2003 until 2007, he collaborates with ALPHA TV Station, as Executive Vice President and General Director of News and Information department and later, as Chairman and CEO.

From April 2007 until October 2011 he collaborates with ALTER TV station.

In September 2007 he founded along with Andreas Kouris the «Real Group», which owns the radio station “Real Fm 97.8” in Athens, “Real Fm 107.1” in Salonica, “Ellinikos 93,2” in Athens, the weekly (every Sunday) newspaper “Real News” and the news portal “Real.gr”.

In 2012 Nikos Chatzinikolaou created his own personal site-blog “Enikos.gr” and the financial news blog “Enikonomia.gr”.

From September 2013 until June 2016, he collaborates with STAR Channel TV Station.

Since January 2017, he is the anchorman of the main news edition of ANT1 TV Station.

Nikos Chatzinikolaou is board member of European Newspaper Publishers Association (ENPA).

She studied Political Sciences at the Department of Law of the National and Kapodistrian University of Athens and media training at the BBC Academy. She is a journalist, political analyst, TV anchorwoman until 2011 and General Manager of the think tank Institute of Democracy, Konstantinos Karamanlis until 2014.

She is an experienced and distinguished media trainer for “tradional” and cyber crisis management in companies such as: PETROLA HELLAS, HELLENIC PETROLEUM (ELPE), LAFARGE BETON, HALYPS BUILDING MATERIALS, ITALCEMENTI GROUP, REGENCY CASINO THESSALONIKI, HSBC, CREDIT AGRICOLE LIFE, DELTA, KATSELIS, GOODY’S, EVEREST, CARREFOUR, GENESIS FARMA and others.

Katia Makri is a journalist at Antenna Channel, one of the leading television networks in Greece. She has more than 20 years of experience as a political editor, and worked during that time for Ethnos, Eleftherotypia and Real newspapers, Star Channel, Alter Channel, Real, Alpha, and Flash Radio.

She was born in Athens, she has a master in European Studies and speaks fluently English and Italian.

Emilia Stathakou is an accredited editor of the Ministry of Health at Realnews and Realfm and Editorial Director at Oloygeia.gr.

She has over 30 years of experience in medical reporting and has collaborated with print, web and radio media, as well as with the Athens Medical Association as the head of the Press Office.

She is a graduate of the Department of Psychology, the Philosophical School of Athens.

Alexandros Kontis has studied Political Science and History and has a Master’s Degree in Environmental Governance and Sustainable Development. He is a journalist since 2002. He has worked for leading daily and weekly newspapers, in magazines and radio boradcasters.

Today he is the Editor in Chief in Realnews and hosts a news radio show at RealFM 97,8.